Updated:
Indaco Capital
Indaco Capital is a venture capital firm based in China that focuses on healthcare investments. The firm has made 11 investments to date. Its most recent...
Indaco Capital
Indaco Capital is a venture capital firm based in China that focuses on healthcare investments. The firm has made 11 investments to date. Its most recent investment was in ReLive Biotechnologies as part of their Series A funding on January 25, 2023.
General information
Firm type
Venture Capital
Year founded
2015
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
Does Indaco Capital focus on specific technology sectors?
Specific sector concentrations are not publicly disclosed. The firm's mandate covers technology broadly, which in the Chinese context can include enterprise software, deep tech, AI applications, and digital platforms. Without published portfolio companies or stated vertical focuses, the firm's thesis is inferred from its early-stage, Beijing-based position in the market.
Does Indaco Capital lead rounds or participate alongside other investors?
The firm's lead-or-follow posture is not publicly documented. At seed stage in China, boutique managers often lead or co-lead rounds where check sizes are manageable, sometimes as the first institutional capital. Specific co-investment patterns, syndication preferences, or known co-investor relationships have not been disclosed by the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: